Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B

Pediatr Infect Dis J. 2003 Jun;22(6):567-9.

Abstract

A 1.5-year-old infant was referred because of spreading skin lesions diagnosed earlier as cutaneous leishmaniasis that did not respond to repeated courses with paromomycin-containing ointment. After consideration of the alternative therapeutic options, the infant was treated with a topical colloidal solution of amphotericin B for 3 weeks, This mode of therapy resulted in resolution of the skin lesions. No local or systemic side effects were observed. There were no signs of recurrence 3 months after cessation of the treatment.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Amphotericin B / administration & dosage*
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Leishmaniasis, Cutaneous / diagnosis*
  • Leishmaniasis, Cutaneous / drug therapy*
  • Recurrence
  • Severity of Illness Index
  • Solutions
  • Treatment Outcome

Substances

  • Solutions
  • Amphotericin B